Today: 9 June 2026
Unilever shares slip in early London trade — what investors watch before Feb 12 results
7 January 2026
1 min read

Unilever shares slip in early London trade — what investors watch before Feb 12 results

London, Jan 7, 2026, 08:55 GMT — Regular session

Unilever PLC shares fell 0.9% to 4,703.5 pence by 08:28 GMT, leaving them down about 2.5% since Jan. 2. The stock traded between 4,698 and 4,750 pence and is about 5% below its 52-week high of 4,930 pence.

The move came as European shares paused after a string of record closes, with investors weighing U.S.-Venezuela headlines and a busy economic calendar. Oil prices fell after U.S. President Donald Trump said Washington had struck a deal to import $2 billion worth of Venezuelan crude, while Nestle slid after recalling some batches of infant nutrition products over possible contamination.

Investors have also been digesting Unilever’s post-ice-cream overhaul after the group split off its Magnum business in December. In the same month, Unilever said it would consolidate shares at an 8-for-9 ratio after completing the demerger.

“Our performance excluding Ice Cream showed good sequential improvement, with a step up in volume growth,” chief executive Fernando Fernandez said in Unilever’s October trading update. The company reiterated its full-year outlook for 3%-5% underlying sales growth — a measure that strips out currency swings and deal effects — and said it still expected €800 million of productivity savings. It forecast about €650 million of those savings by end-2025, with the remaining €150 million to come in 2026. Unilever

London’s FTSE 100 closed at a record high on Tuesday, rising 1.4% to 10,112.73 points, after AstraZeneca jumped on a strategic collaboration announcement and a weaker pound helped exporters. The benchmark has started 2026 strongly, with investors pricing in Bank of England rate cuts later this year.

But Unilever’s next update will need to show steady volume-led growth and clean execution after the ice cream separation, or investors may question how much of the recent sales momentum is coming from price rises rather than demand. A sharp swing in currencies or renewed cost inflation would also test margins in 2026.

Stock Market Today

  • NOV Stock Up 32% in Six Months: Key Factors and Investor Outlook
    June 9, 2026, 10:21 AM EDT. NOV Inc. shares have surged 31.5% over six months, outpacing the Mechanical and Equipment Oil and Gas sub-industry and broader energy sector. The company benefits from strong offshore equipment demand, driven by subsea flexible pipe growth and offshore projects through 2028. NOV's focus on automation and cost reduction, including headcount and facility cuts, supports operational efficiency. Management anticipates a multi-year upcycle in capital equipment spending due to energy security and renewed offshore investment, bolstering demand. With a solid backlog and positive 2026 earnings outlook, NOV's positioning suggests potential for continued gains, raising questions for investors on whether to hold or sell amid market shifts.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Applied Materials stock jumps to a fresh 52-week high as CES AI talk lifts chip-equipment shares
Previous Story

Applied Materials stock jumps to a fresh 52-week high as CES AI talk lifts chip-equipment shares

Intel stock today: INTC steadies before the bell as CES “Panther Lake” chips put 18A under the microscope
Next Story

Intel stock today: INTC steadies before the bell as CES “Panther Lake” chips put 18A under the microscope

Go toTop